VCYT - Veracyte Inc News Story
$47.51 0.6 1.3%
Last Trade - 05/03/21
| Market Cap | £2.30bn |
| Enterprise Value | £2.05bn |
| Revenue | £84.9m |
| Position in Universe | 1764th / 6651 |
BRIEF-Veracyte Announces New Data Published In Journal Of Clinical Oncology Suggest The Prosigna Breast Cancer Test’S Genomic Underpinning Drives Prognostic Performance
Fri 30th October, 2020 3:06pm
Oct 30 (Reuters) - Veracyte Inc VCYT.O :
* VERACYTE ANNOUNCES NEW DATA PUBLISHED IN JOURNAL OF
CLINICAL
ONCOLOGY SUGGEST THE PROSIGNA BREAST CANCER TEST’S GENOMIC
UNDERPINNING DRIVES PROGNOSTIC PERFORMANCE
Source text for Eikon: ID:nBw14qtvwa
Further company coverage: VCYT.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on Veracyte Inc
See all news
